跳至主要內容

藥物交互作用

Atezolizumab + Siponimod

嚴重程度: 中度

Atezolizumab and Siponimod: moderate interaction.

最後更新

僅供醫療專業人員參考。本頁為簡要摘要,並非醫療建議,亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。

本頁的臨床內容僅提供英文版。

摘要

Atezolizumab enhances immune activity by blocking PD-L1, and siponimod reduces circulating lymphocytes, so the two act in opposing directions. Siponimod could weaken the antitumour effect of atezolizumab, and the combination might alter the risk of immune-related adverse events in unpredictable ways.

用白話說明這項交互作用的意義

Atezolizumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Atezolizumab belongs to Oncology; Siponimod belongs to Central Nervous System.

證據等級: Low

為什麼會發生

Pharmacodynamic opposition between lymphocyte sequestration by siponimod and T-cell reactivation by PD-L1 blockade; not well characterised clinically.

處置方式

Avoid starting siponimod in patients receiving checkpoint inhibitors unless clearly needed; monitor lymphocyte counts, infection and immune-related adverse events.

可向藥師詢問的問題

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ 會員專屬

解鎖完整頁面

建立帳號並開始 Pro+ 試用,即可解鎖 Atezolizumab 與 Siponimod 的完整臨床處置建議、補充說明、證據詳情及整張處方的交互作用檢查工具。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

在網頁版免費試用 Pro+ 14 天,無需信用卡。

常見問題

Can I take Atezolizumab with Siponimod?

MediHelp rates the interaction as moderate. Atezolizumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Atezolizumab enhances immune activity by blocking PD-L1, and siponimod reduces circulating lymphocytes, so the two act in opposing directions. Siponimod could weaken the antitumour effect of atezolizumab, and the combination might alter the risk of immune-related adverse events in unpredictable ways.

How serious is the interaction between Atezolizumab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid starting siponimod in patients receiving checkpoint inhibitors unless clearly needed; monitor lymphocyte counts, infection and immune-related adverse events.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查

在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用,並使用劑量工具。

依 A–Z 瀏覽 · 藥物交互作用

取得 App 登入